G
Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
NSE:GLS
Price:
1 100.6
INR
-2.89%
Market Closed
Market Cap:
₹134.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
IN |
|
Z
|
Zhejiang Zoenn Design Co Ltd
SZSE:300901
|
CN |
|
H
|
Hankuk Carbon Co Ltd
KRX:017960
|
KR |
|
I
|
Indigo Exploration Inc
XTSX:IXI
|
CA |
|
AutoCanada Inc
TSX:ACQ
|
CA |
|
Apex Frozen Foods Ltd
NSE:APEX
|
IN |
|
A
|
Ambitions Enterprise Management Co LLC
NASDAQ:AHMA
|
AE |
|
N
|
Nivika Fastigheter AB (publ)
STO:NIVI B
|
SE |
|
Cellnex Telecom SA
MAD:CLNX
|
ES |
|
Hello Group Inc
NASDAQ:MOMO
|
CN |
|
P
|
Patrizia SE
SWB:PAT
|
DE |
|
Ally Financial Inc
NYSE:ALLY
|
US |
|
A
|
Arad Ltd
TASE:ARD
|
IL |
|
Gear Energy Ltd
TSX:GXE
|
CA |
|
G
|
Getty Copper Inc
XTSX:GTC
|
CA |
|
Manuka Resources Ltd
ASX:MKR
|
AU |
|
Banco Bradesco SA
BOVESPA:BBDC4
|
BR |
|
Earlypay Ltd
ASX:EPY
|
AU |
|
Source Energy Services Ltd
TSX:SHLE
|
CA |
|
S
|
Silla SG Co Ltd
KOSDAQ:025870
|
KR |
|
D
|
Da Zhong Trading Group Holding Co
OTC:DZGH
|
CN |
Cash Flow Statement
Cash Flow Statement
Glenmark Life Sciences Ltd
Glenmark Life Sciences Ltd
Currency: INR
| Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Net Income |
5 649
|
5 673
|
6 286
|
6 797
|
6 313
|
5 681
|
|
| Depreciation & Amortization |
379
|
391
|
421
|
480
|
535
|
572
|
|
| Other Non-Cash Items |
399
|
40
|
183
|
179
|
378
|
361
|
|
| Cash Taxes Paid |
1 382
|
1 259
|
1 536
|
1 589
|
1 630
|
1 685
|
|
| Cash Interest Paid |
1
|
0
|
5
|
0
|
15
|
22
|
|
| Change in Working Capital |
(451)
|
(2 248)
|
(3 830)
|
(2 913)
|
(3 091)
|
(2 445)
|
|
| Cash from Operating Activities |
5 976
N/A
|
3 856
-35%
|
3 060
-21%
|
4 543
+48%
|
4 135
-9%
|
4 169
+1%
|
|
| Investing Cash Flow | |||||||
| Capital Expenditures |
(1 322)
|
(1 865)
|
(1 628)
|
(1 319)
|
(1 290)
|
(1 519)
|
|
| Other Items |
99
|
129
|
161
|
160
|
125
|
175
|
|
| Cash from Investing Activities |
(1 222)
N/A
|
(1 736)
-42%
|
(1 467)
+15%
|
(1 158)
+21%
|
(1 165)
-1%
|
(1 344)
-15%
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Common Stock |
10 119
|
0
|
0
|
0
|
0
|
1
|
|
| Net Issuance of Debt |
(9 619)
|
(16)
|
(11)
|
(28)
|
(22)
|
(15)
|
|
| Cash Paid for Dividends |
(1 287)
|
(2 573)
|
(3 859)
|
(2 573)
|
(2 757)
|
0
|
|
| Other |
(1)
|
0
|
(5)
|
0
|
(15)
|
(22)
|
|
| Cash from Financing Activities |
(788)
N/A
|
(2 736)
-247%
|
(3 876)
-42%
|
(2 601)
+33%
|
(2 794)
-7%
|
(2 793)
+0%
|
|
| Change in Cash | |||||||
| Net Change in Cash |
3 966
N/A
|
(617)
N/A
|
(2 283)
-270%
|
784
N/A
|
176
-78%
|
32
-82%
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
4 654
N/A
|
1 991
-57%
|
1 432
-28%
|
3 224
+125%
|
2 845
-12%
|
2 650
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
